Pediatric Nephrology

, Volume 26, Issue 5, pp 705–711 | Cite as

Fetal environment, epigenetics, and pediatric renal disease

  • Robert Woroniecki
  • Anil Bhanudas Gaikwad
  • Katalin Susztak
Educational Review

Abstract

The notion that some adult diseases may have their origins in utero has recently captured scientists’ attention. Some of these effects persist across generations and may involve epigenetic mechanisms. Epigenetic modifications, DNA methylation together with covalent modifications of histones, alter chromatin density and accessibility of DNA to cellular machinery, modulating the transcriptional potential of the underlying DNA sequence. Here, we will discuss the different epigenetic modifications and their potential role in and contribution to renal disease development.

Keywords

Epigenetics Intrauterine environment Histone modification DNA methylation 

References

  1. 1.
    Wood AJ, Oakey RJ (2006) Genomic imprinting in mammals: emerging themes and established theories. PLoS Genet 2:e147PubMedCrossRefGoogle Scholar
  2. 2.
    Knoll JH, Nicholls RD, Magenis RE, Graham JM Jr, Lalande M, Latt SA (1989) Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet 32:285–290PubMedCrossRefGoogle Scholar
  3. 3.
    Knoll JH, Nicholls RD, Magenis RE, Glatt K, Graham JM Jr, Kaplan L, Lalande M (1990) Angelman syndrome: three molecular classes identified with chromosome 15q11q13-specific DNA markers. Am J Hum Genet 47:149–154PubMedGoogle Scholar
  4. 4.
    Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460:1132–1135PubMedCrossRefGoogle Scholar
  5. 5.
    Yamanaka S (2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature 460:49–52PubMedCrossRefGoogle Scholar
  6. 6.
    Yamanaka S (2009) A fresh look at iPS cells. Cell 137:13–17PubMedCrossRefGoogle Scholar
  7. 7.
    Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4:143–153PubMedCrossRefGoogle Scholar
  8. 8.
    Dressler GR (2008) Epigenetics, development, and the kidney. J Am Soc Nephrol 19:2060–2067PubMedCrossRefGoogle Scholar
  9. 9.
    Pembrey ME, Bygren LO, Kaati G, Edvinsson S, Northstone K, Sjostrom M, Golding J (2006) Sex-specific, male-line transgenerational responses in humans. Eur J Hum Genet 14:159–166PubMedCrossRefGoogle Scholar
  10. 10.
    Kaati G, Bygren LO, Pembrey M, Sjostrom M (2007) Transgenerational response to nutrition, early life circumstances and longevity. Eur J Hum Genet 15:784–790PubMedCrossRefGoogle Scholar
  11. 11.
    Zandi-Nejad K, Luyckx VA, Brenner BM (2006) Adult hypertension and kidney disease: the role of fetal programming. Hypertension 47:502–508PubMedCrossRefGoogle Scholar
  12. 12.
    Luyckx VA, Brenner BM (2005) Low birth weight, nephron number, and kidney disease. Kidney Int Suppl S68–S77Google Scholar
  13. 13.
    Alexander BT (2003) Intrauterine growth restriction and reduced glomerular number: role of apoptosis. Am J Physiol Regul Integr Comp Physiol 285:R933–R934PubMedGoogle Scholar
  14. 14.
    Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE (2006) Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int 69:671–678PubMedCrossRefGoogle Scholar
  15. 15.
    McGraw M, Poucell S, Sweet J, Baumal R (1984) The significance of focal segmental glomerulosclerosis in oligomeganephronia. Int J Pediatr Nephrol 5:67–72PubMedGoogle Scholar
  16. 16.
    Hodgin JB, Rasoulpour M, Markowitz GS, D’Agati VD (2009) Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4:71–76PubMedCrossRefGoogle Scholar
  17. 17.
    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 342:381–389Google Scholar
  18. 18.
    Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G (2008) Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diab Care 31:2006–2012CrossRefGoogle Scholar
  19. 19.
    El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205:2409–2417PubMedCrossRefGoogle Scholar
  20. 20.
    Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A (2009) Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that co-exist on the lysine tail. Diabetes 58:1229–1236PubMedCrossRefGoogle Scholar
  21. 21.
    White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM (2008) Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthal 126:1707–1715PubMedCrossRefGoogle Scholar
  22. 22.
    Dressler GR (2009) Advances in early kidney specification, development and patterning. Development 136:3863–3874Google Scholar
  23. 23.
    Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP (2005) Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 9:283–292PubMedCrossRefGoogle Scholar
  24. 24.
    Patel SR, Kim D, Levitan I, Dressler GR (2007) The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev Cell 13:580–592PubMedCrossRefGoogle Scholar
  25. 25.
    Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315–322PubMedCrossRefGoogle Scholar
  26. 26.
    Fazzari MJ, Greally JM (2004) Epigenomics: beyond CpG islands. Nat Rev 5:446–455CrossRefGoogle Scholar
  27. 27.
    Chow J, Heard E (2009) X inactivation and the complexities of silencing a sex chromosome. Curr Opin Cell Biol 21:359–366PubMedCrossRefGoogle Scholar
  28. 28.
    Agrelo R, Wutz A (2009) X inactivation and disease. Semin Cell Dev Biol 21:194–200PubMedGoogle Scholar
  29. 29.
    Reik W, Dean W, Walter J (2001) Epigenetic reprogramming in mammalian development. Science 293:1089–1093PubMedCrossRefGoogle Scholar
  30. 30.
    Razin A (1998) CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J 17:4905–4908PubMedCrossRefGoogle Scholar
  31. 31.
    Ho KL, McNae IW, Schmiedeberg L, Klose RJ, Bird AP, Walkinshaw MD (2008) MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol Cell 29:525–531PubMedCrossRefGoogle Scholar
  32. 32.
    Lasalle JM, Yasui DH (2009) Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 1:119–130PubMedCrossRefGoogle Scholar
  33. 33.
    Bechtel W, McGoohan S, Zeisberg EM, Muller GA, Kalbacher H, Salant DJ, Muller CA, Kalluri R, Zeisberg M (2010) Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16:544–550PubMedCrossRefGoogle Scholar
  34. 34.
    Einstein F, Thompson RF, Bhagat TD, Fazzari MJ, Verma A, Barzilai N, Greally JM (2010) Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One 5:e8887PubMedCrossRefGoogle Scholar
  35. 35.
    Marmorstein R, Trievel RC (2009) Histone modifying enzymes: structures, mechanisms, and specificities. Biochim Biophys Acta 1789:58–68PubMedGoogle Scholar
  36. 36.
    Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447:407–412PubMedCrossRefGoogle Scholar
  37. 37.
    Guil S, Esteller M (2009) DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 41:87–95PubMedCrossRefGoogle Scholar
  38. 38.
    Sayyed SG, Gaikwad AB, Lichtnekert J, Kulkarni O, Eulberg D, Klussmann S, Tikoo K, Anders HJ (2010) Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol Dial Transplant 25:1811–1817PubMedCrossRefGoogle Scholar
  39. 39.
    Gaikwad AB, Sayyed SG, Lichtnekert J, Tikoo K, Anders HJ (2010) Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes. Am J Pathol 176:1079–1083PubMedCrossRefGoogle Scholar
  40. 40.
    Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, Natarajan R (2008) Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283:26771–26781PubMedCrossRefGoogle Scholar
  41. 41.
    Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R (2008) Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA 105:9047–9052PubMedCrossRefGoogle Scholar
  42. 42.
    Pentz ES, Lopez ML, Kim HS, Carretero O, Smithies O, Gomez RA (2001) Ren1d and Ren2 cooperate to preserve homeostasis: evidence from mice expressing GFP in place of Ren1d. Physiol Genomics 6:45–55PubMedGoogle Scholar
  43. 43.
    Gomez RA, Pentz ES, Jin X, Cordaillat M, Sequeira Lopez ML (2009) CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. Am J Physiol Heart Circ Physiol 296:H1255–H1262PubMedCrossRefGoogle Scholar
  44. 44.
    Bjornsson HT, Fallin MD, Feinberg AP (2004) An integrated epigenetic and genetic approach to common human disease. Trends Genet 20:350–358PubMedCrossRefGoogle Scholar
  45. 45.
    Wilson AG (2008) Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 79:1514–1519PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2010

Authors and Affiliations

  • Robert Woroniecki
    • 1
  • Anil Bhanudas Gaikwad
    • 2
  • Katalin Susztak
    • 2
    • 3
  1. 1.Department of Pediatrics, NephrologyAlbert Einstein College of MedicineBronxUSA
  2. 2.Department of Medicine, Division of NephrologyAlbert Einstein College of MedicineBronxUSA
  3. 3.Department of GeneticsAlbert Einstein College of MedicineBronxUSA

Personalised recommendations